A freeze-dried peptide looks like the most stable object in any laboratory: a small white cake at the bottom of a sealed glass vial, dry to the touch, apparently untouched by time. That impression is half right. Lyophilization slows chemical breakdown dramatically, but it does not stop it, and how quickly breakdown resumes depends on two facts that a purity figure never shows: how much water is still in the cake, and what the vial went through after the day it was tested.
In Costa Rica, where humidity is part of daily life for most of the year, the distance between test day and bench day is worth understanding properly. The mechanics are not exotic. They come from basic chemistry, from how stability scientists think about hot and humid climates, and from what a standard analytical report does and does not measure.
What freeze-drying actually removes
Lyophilization works in stages. The solution is frozen, the ice is converted straight into vapor under vacuum (sublimation), and a secondary drying step drives off much of the remaining bound water. What is left is a porous solid with very little moisture in it.
That matters because water is the medium in which most peptide degradation happens. Hydrolysis cuts the chain at its bonds. Deamidation alters asparagine and glutamine residues. Aggregation lets molecules clump into forms the original assay was never designed to detect. All of these reactions run faster when mobile water is present, so removing it is the whole point of the process.
But “very little” is not “none”. A finished cake still carries residual moisture, which is why manufacturers of freeze-dried products set an upper limit for it. Many peptide powders are also hygroscopic, meaning they pull water vapor out of the surrounding air. A vial with a marginal seal, or one opened in damp air, can gain water without any change you could see with the naked eye.
Why Costa Rica turns a lab detail into a practical question
The country’s national weather service, the Instituto Meteorologico Nacional, describes a pronounced wet season across much of the Pacific side, running roughly from May into November, while the Caribbean slope follows a different pattern with rain spread through most of the year. Coastal air stays humid even on dry days, and afternoon storms are a regular feature of the green season.
Now picture the ordinary journey of a vial: a loading dock, a courier vehicle, a storeroom without climate control, a second storeroom. Each stop is a small environment with its own temperature and humidity, and almost nobody tested them. None of this means material degrades in Costa Rica. It means the question “what condition is this in now?” cannot be answered by a document alone, in any place where heat and humidity run high.
How stability scientists put numbers on a hot, humid shelf
Drug regulators have a formal vocabulary for this problem. The ICH guideline Q1A(R2) on stability testing divides the world into climatic zones. Temperate regions are tested at around 25 degrees Celsius and 60 percent relative humidity, while the hot and humid zones are tested at around 30 degrees and 65 to 75 percent. Costa Rica’s lowlands sit much closer to the second description than the first.
A caveat belongs here. That guideline was written for medicines moving through regulatory approval, not for research reagents sold to laboratories, so it is a yardstick for thinking, not a rule that governs any particular vial. What it does show is how seriously regulators treat heat and humidity: as measurable variables, with dedicated studies, rather than as assumptions.
Appearance is a poor witness
The obvious shortcut is to look at the vial. A collapsed or shrunken cake, a yellow tint or a sticky, glassy texture can point to moisture uptake. But the reverse does not hold. A perfect-looking white puck can still have drifted in water content or accumulated degradation products at levels only an instrument would catch. Visual inspection can raise a flag. It can never clear one.
What a lab report tells you, and what it leaves out
A typical analytical report for a peptide lot contains two core results. HPLC, or high-performance liquid chromatography, separates the sample and reports what share of the detector signal belongs to the main peak. That share is the purity percentage. Mass spectrometry measures molecular mass and confirms that the compound is what the label says it is. Both are valuable, and buyers who want to see them can start with published lab test results that name the lot, the method and the date of analysis.
Here is what that kind of report does not give you. HPLC purity is an area percentage, so it says nothing about how much of the powder’s weight is peptide and how much is water, salts and counterions. Net peptide content needs its own determination, usually through amino acid analysis. Water content is measured by a different method again, commonly Karl Fischer titration. A report that shows only a purity chromatogram contains neither number.
And every result is dated. It describes a sample drawn from a lot on the day of analysis. It cannot describe the vial that left the building afterward.
The gap between test day and bench day
Consider a lot that tests clean in one month and is used in another. In between come filling, sealing, labeling, packing, transport, customs paperwork where it applies, a storeroom, a courier and a second storeroom. Every step has a duration and a temperature that someone could record, and usually nobody does. The longer and less documented the chain, the wider the gap between what the report says and what the vial now holds.
This is the practical argument for shorter routes. For a buyer in Costa Rica, a catalog based inside the country, such as Peptides Costa Rica, can in principle shorten that chain by removing the international leg, with its customs queues and the days parcels spend waiting in hubs. The full product list shows what is on offer.
The words “in principle” carry weight. A shorter route is only an advantage if the supplier can show how the material was held between testing and handover. Distance is easy to claim. Documentation is what proves it.
Questions worth asking any supplier
None of these require a laboratory of your own. They require only that the answers exist.
- Is the report for the specific lot in the vial, and does it carry the date of analysis?
- Is the analytical method named, and was the testing done by a lab the supplier does not own?
- Is water content reported, or only purity?
- Is net peptide content stated, or only an area percentage?
- Can the supplier say how long the lot has been held, and under what conditions?
A supplier who answers all five has probably thought about the shelf. One who answers only the first has handed you a snapshot and asked you to trust the rest.
What this article does not claim
It does not report a measured rate of degradation for any specific compound under Costa Rican conditions. Numbers like that come only from stability data on the lot in question, generated under defined temperature and humidity, and anyone quoting a figure without that data is guessing. It also does not suggest that humid climates ruin freeze-dried material. The claim is narrower: heat and humidity are variables, variables can be recorded, and a document that records none of them leaves a gap.
The materials discussed here are laboratory reagents, not approved medicines, and nothing in this piece is guidance for use on people.
A purity number tells you what was in the vial on one afternoon. The date printed beside it is the most honest line on the page, because it marks exactly where the report’s knowledge ends.
